Physician profile
Susan E Kirk
NPI 1154575561
$27,645.67
in general payments reported to CMS, 2019-2025
10 companies · $225 in 2025
The $225 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,520 · 2022: $6,618 · 2023: $12K · 2024: $6,326 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Travel and Lodging: $3,848 · Food and Beverage: $1,490 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $225.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,944.00 |
| Travel and Lodging | $3,848.28 |
| Food and Beverage | $1,490.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $225.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $17,137.75 | 2023-2024 | |
| Biomarin Pharmaceutical INC. | $9,025.26 | 2021-2023 | Roctavian |
| Hema Biologics, LLC | $821.93 | 2024 | Sevenfact |
| Novartis Pharmaceuticals Corporation | $241.05 | 2023-2025 | |
| Sobi, INC | $135.18 | 2024 | |
| Agios Pharmaceuticals, INC. | $101.34 | 2023 | Pyrukynd |
| Apellis Pharmaceuticals, INC. | $84.40 | 2022 | |
| Alexion Pharmaceuticals, INC. | $47.61 | 2022 | |
| Daiichi Sankyo INC. | $26.20 | 2023 | Injectafer |
| Servier Pharmaceuticals LLC | $24.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.